Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Carcinosarcoma × dostarlimab × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Neoplasms 13 Endometrial Neoplasms 12 Carcinoma, Non-Small-Cell Lung 9 Uterine Cervical Neoplasms 5 Ovarian Neoplasms 5 Neoplasm Metastasis 5 Squamous Cell Carcinoma of Head and Neck 4 Rectal Neoplasms 4 Colonic Neoplasms 4 Breast Neoplasms 4 Pancreatic Neoplasms 3 Melanoma 3 Head and Neck Neoplasms 3 Stomach Neoplasms 2 Osteosarcoma 2 Locally Advanced Rectal Cancer (LARC) 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Neuroendocrine 2 Carcinoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1

Interventions

niraparib 1 dostarlimab 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03651206 2025-12-19

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡